ArisGlobal - About the company
ArisGlobal is an acquired company based in Princeton (United States), founded in 1986 by Deepak Abbhi. It operates as a Platform providing drug development solutions using cognitive computing. ArisGlobal has raised an undisclosed amount in funding. The company has 164 active competitors, including 22 funded and 24 that have exited. Its top competitors include companies like Owkin, Novotech and Atomwise.
Company Details
ArisGlobal provides a cloud-based platform for helping the healthcare industry in the drug development process. Uses its proprietary Nava cognitive computing engine and provides automation in the development process, integrates document management solution across the product lifecycle and provides drug safety solutions. Practice areas include pharmacovigilance and safety, regulatory affairs, clinical research (clinical trial management, electronic data capture & supply chain management) and medical communications. Clients include AstraZeneca, Teva, Roche and more.
- Website
- arisglobal.com
- Registered Address
- REGUS WOLVERHAMPTON SALOP STREET,FLOORS 3 AND 4 84 SALOP STREET,WOLVERHAMPTON SALOP STREET,ENGLAND,WV3 0SR
Key Metrics
Founded Year
1986
Location
Princeton, United States
Stage
Acquired
Latest Funding Round
Investors
Ranked
24th among 164 active competitors
Employee Count
2,012 as on Jan 13, 2026
Similar Companies
Exit Details
Acquired by Nordic Capital (Jun 17, 2019)
Legal entities associated with ArisGlobal
ArisGlobal is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ARISGLOBAL UK LIMITED CIN: 4428059 , United Kingdom, Active | Apr 29, 2002 | - | 6 (As on Dec 31, 2022) | |
ARISGLOBAL, LLC CIN: 6223150 , United States, Active | Jul 19, 2021 | - | - | - |
ARISGLOBAL SOFTWARE PRIVATE LIMITED CIN: U72200KA2004PTC033761 , India, Active | Apr 16, 2004 | - | 1113 (As on Mar 31, 2024) |
ArisGlobal's acquisition details
ArisGlobal got acquired by Nordic Capital on Jun 17, 2019 at an acquisition amount of $700M.
Click here to take a look at ArisGlobal's acquisition in detail
Sign up to download ArisGlobal's company profile
ArisGlobal's funding and investors
ArisGlobal has raised funding over 1 round. Its latest funding round was a Unattributed round on 2017 for $*****. 1 investor participated in its latest round. ArisGlobal has 2 institutional investors.
Here is the list of recent funding rounds of ArisGlobal:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2017 | 3149 | Unattributed | 1189 | 3722 | 4366 | 8491 |
View details of ArisGlobal's funding rounds and investors
ArisGlobal's founders and board of directors
Founder? Claim ProfileThe founders of ArisGlobal is Deepak Abbhi.
Here are the details of ArisGlobal's key team members:
- Deepak Abbhi: Former Founder of ArisGlobal.
View details of ArisGlobal's Founder profiles and Board Members
ArisGlobal's employee count trend
ArisGlobal has 2,012 employees as of Jan 26. Here is ArisGlobal's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ArisGlobal's Competitors and alternates
Top competitors of ArisGlobal include Owkin, Novotech and Atomwise. Here is the list of Top 10 competitors of ArisGlobal, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of agentic AI platform for biomedical research and drug development | $354M | 71/100 | ||
2nd | Provider of clinical research services across all trial phases and therapeutic areas | $255M | 68/100 | ||
3rd | Atomwise 2012, San Francisco (United States), Series B | Developer of artificial intelligence platform for small molecule drug discovery | $219M | 68/100 | |
4th | Antiverse 2017, Cardiff (United Kingdom), Series A | Developer of computational platform for de novo design of antibody therapeutics | $20M | 68/100 | |
5th | Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired | AI powered scientific data management and workflow automation solutions | $11.3M | 65/100 | |
6th | Concert AI 2018, Boston (United States), Series C | Provider of AI and real-world data solutions for life sciences | $300M | 63/100 | |
7th | Developer of AI foundation model to transform biological research | $76M | 62/100 | ||
8th | Digital Science 2010, London (United Kingdom), Funding Raised | Research assistance software solutions | - | 59/100 | |
9th | Doctor Evidence 2004, Santa Monica (United States), Acquired | Evidence based medical decision solutions for multiple healthcare stakeholders | $1.5M | 56/100 | |
10th | Sygnature Discovery 2004, Nottingham (United Kingdom), Series A | Provider of services and products for integrated drug discovery | - | 56/100 | |
24th | ArisGlobal 1986, Princeton (United States), Acquired | Platform providing drug development solutions using cognitive computing | - | 48/100 |
Looking for more details on ArisGlobal's competitors? Click here to see the top ones
ArisGlobal's Investments and acquisitions
ArisGlobal has acquired 2 companies including Sporify and Amplexor Life Science. ArisGlobal has not made any investments as of now.News related to ArisGlobal
Media has covered ArisGlobal for a total of 19 events in the last 1 year, 16 of them have been about company updates and 1 about partnerships.
•
ArisGlobal Launches NavaX Translation for Global PharmacovigilancePR Newswire•Feb 27, 2026•ArisGlobal
•
•
•
ArisGlobal Announces XDI NavaX Data Intelligence and Three New AgentsAiThority•Feb 11, 2026•ArisGlobal
•
ArisGlobal accelerates AI growth and adoption after strong 2025 performanceEuropa Press•Jan 14, 2026•ArisGlobal
•
EPS Corporation Selects ArisGlobal's LifeSphere® MultiVigilance APACPR Newswire•Dec 18, 2025•ArisGlobal, EPS Corporation
•
Virtual Assistants Turn to AI as Industry Enters New Era of ProductivityMarTech Series•Nov 03, 2025•ArisGlobal
•
•
•
Are you a Founder ?
FAQs about ArisGlobal
Explore our recently published companies
- Primesnailmucus - Unfunded company
- Enzobiotica - Unfunded company
- Xman4289 - 2022 founded, Unfunded company
- Dcustomdesigns - Unfunded company
- Goodnighties - 2007 founded, Unfunded company
- Barbosa - 1989 founded, Public company